Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France.
Association française des centres d’addictovigilance; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. Association française des centres d’addictovigilance, et al. Among authors: libert f. Therapie. 2021 Jan-Feb;76(1):53-54. doi: 10.1016/j.therap.2020.01.001. Epub 2020 Jan 17. Therapie. 2021. PMID: 32005483 French. No abstract available.
Warning on increased serious health complications related to non-medical use of nitrous oxide.
French Association of Addictovigilance Centres; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. French Association of Addictovigilance Centres, et al. Among authors: libert f. Therapie. 2021 Sep-Oct;76(5):478-479. doi: 10.1016/j.therap.2020.01.002. Epub 2020 Jan 17. Therapie. 2021. PMID: 32063400 No abstract available.
[Practical information for therapeutic drug monitoring of the most common compounds].
Saint-Marcoux F, Libert F; groupe Suivi thérapeutique pharmacologique de la Société française de pharmacologie et de thérapeutique. Saint-Marcoux F, et al. Among authors: libert f. Therapie. 2016 Sep;71(4):405-34. doi: 10.1016/j.therap.2016.01.007. Epub 2016 May 4. Therapie. 2016. PMID: 27203171 French.
[Level of evidence for therapeutic drug monitoring of itraconazole].
Charles M, Le Guellec C, Richard D, Libert F; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Charles M, et al. Among authors: libert f. Therapie. 2011 Mar-Apr;66(2):103-8. doi: 10.2515/therapie/2011015. Epub 2011 Jun 6. Therapie. 2011. PMID: 21635856 Review. French.
[Therapeutic drug monitoring of olanzapine].
Djerada Z, Brousse G, Niel P, Llorca PM, Eschalier A, Bentue-Ferrer D, Libert F; groupe suivi thérapeutique pharmacologique de la Société française de pharmacologie et de thérapeutique. Djerada Z, et al. Among authors: libert f. Therapie. 2023 Sep-Oct;78(5S):S75-S80. doi: 10.2515/therapie/2015040. Epub 2016 Oct 25. Therapie. 2023. PMID: 27793422 French.
Niveau de preuve du suivi thérapeutique pharmacologique de l'itraconazole.
Charles M, Le Guellec C, Richard D, Libert F; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Charles M, et al. Among authors: libert f. Therapie. 2011 Mar-Apr;66(2):103-8. doi: 10.2515/therapie/2011015. Therapie. 2011. PMID: 27393644 French.
[Therapeutic drug monitoring of clozapine].
Djerada Z, Daviet F, Llorca PM, Eschalier A, Saint-Marcoux F, Bentué-Ferrer D, Libert F; Groupe suivi thérapeutique pharmacologique de la Société française de pharmacologie et de thérapeutique. Djerada Z, et al. Among authors: libert f. Therapie. 2023 Sep-Oct;78(5S):S67-S74. doi: 10.2515/therapie/2015041. Epub 2016 Aug 24. Therapie. 2023. PMID: 27771104 French.
152 results